Medicine & Life Sciences
Sarcoma
100%
Osteosarcoma
65%
Neoplasms
50%
regorafenib
40%
Ifosfamide
32%
Rhabdomyosarcoma
30%
Therapeutics
26%
pembrolizumab
24%
Clinical Trials
22%
Response Evaluation Criteria in Solid Tumors
22%
Young Adult
22%
Ewing's Sarcoma
22%
Progression-Free Survival
18%
Pediatrics
18%
Liposarcoma
18%
EPZ-6438
17%
ARRY-470
16%
Drug Combinations
15%
Activating Transcription Factor 1
14%
Phosphotransferases
14%
Diffuse Intrinsic Pontine Glioma
14%
Mutation
13%
Placebos
13%
Alveolar Soft Part Sarcoma
13%
Giant Cell Tumor of Tendon Sheath
13%
Pharmaceutical Preparations
13%
atezolizumab
13%
Bone and Bones
13%
Clear Cell Sarcoma
13%
Protein-Arginine N-Methyltransferases
13%
Colony-Stimulating Factor Receptors
13%
tropomyosin kinase
12%
Oncogene Proteins
11%
Letrozole
11%
Aggressive Fibromatosis
11%
Hormone Antagonists
11%
Chordoma
11%
Nuclear Pore
11%
Chondrosarcoma
11%
Survival
11%
Extremities
10%
Epirubicin
10%
Leiomyosarcoma
10%
Hemangiosarcoma
10%
Amyloid Precursor Protein Secretases
10%
Macrophage Colony-Stimulating Factor
10%
Anthracyclines
9%
Cytostatic Agents
9%
Methotrexate
9%
Mathematics
Drugs
26%
Cancer
17%
Tumor
15%
Therapy
14%
Prediction
13%
Functional Data
12%
Protein
10%
Design
7%
Pathway
7%
Interaction
6%